Teva-levocarbidopa (2018-01-17)

Teva-Levocarbidopa Recall Summary Teva Pharmaceuticals is recalling Levocarbidopa medication across Canada due to a product safety issue. This recall affects patients who have been prescribed this drug, which is used to treat Parkinson's disease. The recall is classified as Class I, indicating a serious safety concern.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2018-01-17

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d7b95309-3dc8-4c5f-bc7b-2fa758b1dc66